Belkin Laser announces $12.2 million raised in series B funding
The company is in the midst of clinical testing of its one-second glaucoma treatment with the product expected to enter the market in two years
Hagar Ravet | 18:26 21.07.2020
Israeli medtech startup Belkin Laser announced on Monday that it completed a $12.2 million series B financing round led by Rimonci Capital and Santen Ventures Inc. CR-CP Life Science Fund, BioLight Life Sciences, and C-Mer Eye Care Holdings also participated in the round. Prior to the current round, Belkin Laser had raised $6.6 million from grants provided by the Israel Innovation Authority incubator grant at the Rad Biomed Accelerator, as well as a European Horizon 2020 grant of $3 million. An additional $2.5 million investment was raised as part of the series A financing round led by ZIG Ventures from Singapore.